Mark Hanson

Title: Mark Hanson - Innovator in Bacterial Lectins

Introduction

Mark Hanson is an accomplished inventor based in Pittsburgh, PA. He has made significant contributions to the field of biotechnology, particularly through his innovative work on lectins derived from bacterial pili. His research has the potential to impact various applications in medicine and biology.

Latest Patents

Mark Hanson holds a patent for "Novel lectins derived from bacterial pili." This patent describes a lectin derived from the pili of piliated organisms. The lectin is characterized by its ability to non-covalently bind to the pilus rod protein of said pili. It can be separated from the pilus by the action of aqueous sodium dodecyl sulfate and possesses a single binding site for binding to mammalian erythrocyte ghosts.

Career Highlights

Mark is currently employed at Bactex, Inc., where he continues to explore the applications of his research. His work has garnered attention in the scientific community, and he is recognized for his innovative approach to studying bacterial proteins.

Collaborations

Mark collaborates with Charles C Brinton, Jr., who is also involved in research at Bactex, Inc. Their combined expertise contributes to the advancement of their projects and the development of new technologies.

Conclusion

Mark Hanson's contributions to the field of biotechnology through his patent on bacterial lectins highlight his innovative spirit and dedication to scientific advancement. His work at Bactex, Inc. continues to pave the way for future discoveries in this important area of research.